0000899243-22-039464.txt : 20221228 0000899243-22-039464.hdr.sgml : 20221228 20221228200022 ACCESSION NUMBER: 0000899243-22-039464 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221223 FILED AS OF DATE: 20221228 DATE AS OF CHANGE: 20221228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Brian Joseph CENTRAL INDEX KEY: 0001776196 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 221496102 MAIL ADDRESS: STREET 1: 480 MORRIS ROAD CITY: BLUE BELL STATE: PA ZIP: 19422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 404-380-9263 MAIL ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 FORMER COMPANY: FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20010815 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-23 0 0001157601 MADRIGAL PHARMACEUTICALS, INC. MDGL 0001776196 Lynch Brian Joseph C/O MADRIGAL PHARMACEUTICALS, INC. 200 BARR HARBOR DRIVE, SUITE 200 WEST CONSHOHOCKEN PA 19428 0 1 0 0 SVP and General Counsel Common Stock 2022-12-23 4 M 0 7000 91.79 A 7000 D Common Stock 2022-12-23 4 S 0 500 267.88 D 6500 D Common Stock 2022-12-23 4 S 0 300 268.99 D 6200 D Common Stock 2022-12-23 4 S 0 700 270.25 D 5500 D Common Stock 2022-12-23 4 S 0 800 271.27 D 4700 D Common Stock 2022-12-23 4 S 0 1500 272.74 D 3200 D Common Stock 2022-12-23 4 S 0 539 273.48 D 2661 D Common Stock 2022-12-23 4 S 0 400 274.70 D 2261 D Common Stock 2022-12-23 4 S 0 100 275.24 D 2161 D Common Stock 2022-12-23 4 S 0 100 276.40 D 2061 D Common Stock 2022-12-23 4 S 0 361 277.77 D 1700 D Common Stock 2022-12-23 4 S 0 1100 279.46 D 600 D Common Stock 2022-12-23 4 S 0 200 280.41 D 400 D Common Stock 2022-12-23 4 S 0 200 281.79 D 200 D Common Stock 2022-12-23 4 S 0 200 283.61 D 0 D Common Stock 530 I In IRA Stock Option (Right to Buy) 91.79 2022-12-23 4 M 0 7000 0.00 D 2030-03-05 Common Stock 7000 25000 D All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 32,000 shares. All exercised options had vested. As to the overall option for 32,000 shares, 25% of the shares underlying the option vested on March 5, 2021 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.32 to $268.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.64 to $269.54, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.72 to $270.69, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.87 to $271.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.18 to $273.14, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.19 to $273.95, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.24 to $275.04, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.51 to $278.13, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.00 to $279.95, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.17 to $280.66, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.45 to $282.14, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.22 to 284.00, inclusive. /s/ Brian J. Lynch 2022-12-28